United Therapeutics Corporation (UTHR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$495.5
Day's range
$530.47

United Therapeutics Corp Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 5.29 M $2.87 B   -1.95% 12.43%
AVORO CAPITAL ADVISORS LLC 08/14/2026 2.78 M $1.51 B   5.62% 6.52%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 1.92 M $1.04 B   -4.21% 4.51%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.92 M $1.04 B   -2.01% 4.50%
STATE STREET CORP 08/07/2026 1.90 M $1.03 B   2.93% 4.46%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 1.71 M $925.85 M   -4.38% 4.01%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 1.38 M $747.20 M   -39.10% 3.24%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 996.60 K $538.86 M   -19.17% 2.34%
JUPITER TOPCO LLC 08/14/2026 831.13 K $450.14 M   100.00% 1.95%
NORGES BANK 08/12/2026 694.75 K $376.44 M   100.00% 1.63%
ASSETMARK, INC 07/30/2026 624.07 K $338.14 M   1.30% 1.46%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 546.00 K $294.64 M   -33.92% 1.28%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 527.90 K $286.05 M   2.96% 1.24%
FMR LLC 08/13/2026 473.41 K $256.51 M   -10.40% 1.11%
INVESCO LTD. 08/14/2026 473.11 K $256.34 M   -22.23% 1.11%
BAILLIE GIFFORD & CO 08/06/2026 467.21 K $253.15 M   9.13% 1.10%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 08/14/2026 457.00 K $247.62 M   0.00% 1.07%
MORGAN STANLEY 08/13/2026 436.70 K $236.62 M   6.70% 1.03%
VESTAL POINT CAPITAL, LP 08/14/2026 435.00 K $235.70 M   480.00% 1.02%
NORTHERN TRUST CORP 08/13/2026 430.84 K $233.44 M   -1.31% 1.01%
MILLENNIUM MANAGEMENT LLC 08/14/2026 409.07 K $221.65 M   166.72% 0.96%
CAPTION MANAGEMENT, LLC 08/14/2026 378.20 K $204.92 M   -7.76% 0.89%
CAPTION MANAGEMENT, LLC 08/14/2026 366.60 K $198.63 M   -45.05% 0.86%
FRANKLIN RESOURCES INC 08/13/2026 340.28 K $184.37 M   22.41% 0.80%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 326.30 K $176.80 M   -31.45% 0.77%
SWEDBANK AB 07/15/2026 323.00 K $175.01 M   -1.26% 0.76%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 318.32 K $172.43 M   6.03% 0.75%
CITADEL ADVISORS LLC 09/02/2026 304.69 K $165.09 M   -15.51% 0.72%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 297.16 K $161.01 M   -1.10% 0.70%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 297.16 K $161.01 M   100.00% 0.70%
BANK OF NEW YORK MELLON CORP 08/06/2026 294.41 K $159.52 M   -10.55% 0.69%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 293.00 K $158.76 M   -17.88% 0.69%
EVERSEPT PARTNERS, LP 08/14/2026 287.67 K $155.87 M   8.85% 0.68%
JANE STREET GROUP, LLC 08/14/2026 285.93 K $154.92 M   10,263.39% 0.67%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 08/14/2026 284.78 K $154.30 M   -17.13% 0.67%
JPMORGAN CHASE & CO 08/12/2026 275.36 K $151.01 M   -5.58% 0.65%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 268.48 K $145.47 M   0.19% 0.63%
LSV ASSET MANAGEMENT 08/06/2026 268.37 K $145.41 M   -32.68% 0.63%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 267.85 K $145.16 M   -13.38% 0.63%
CITIGROUP INC 08/03/2026 262.20 K $142.07 M   11.28% 0.62%
CITADEL ADVISORS LLC 09/02/2026 249.40 K $135.13 M   43.83% 0.59%
FIRST TRUST ADVISORS LP 08/11/2026 249.06 K $134.95 M   -7.95% 0.58%
LORD, ABBETT & CO. LLC 08/14/2026 244.32 K $132.38 M   -2.38% 0.57%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 243.44 K $131.91 M   -39.96% 0.57%
ALLIANCEBERNSTEIN L.P. 08/14/2026 234.61 K $139.12 M   6.33% 0.55%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 233.64 K $126.59 M   89.27% 0.55%
SOLEUS CAPITAL MANAGEMENT, L.P. 08/11/2026 225.59 K $122.23 M   20.51% 0.53%
FULLER & THALER ASSET MANAGEMENT, INC. 08/12/2026 220.70 K $119.58 M   -21.29% 0.52%
UBS GROUP AG 08/13/2026 220.62 K $119.54 M   -6.81% 0.52%
AMUNDI 08/11/2026 219.09 K $118.71 M   48.44% 0.51%

United Therapeutics Corp institutional Ownership - FAQ's

During the previous two years, 1239 institutional investors and hedge funds held shares of United Therapeutics Corp. The most heavily invested institutionals were:

BlackRock, Inc.: 5.29 M

Avoro Capital Advisors LLC: 2.78 M

VANGUARD PORTFOLIO MANAGEMENT LLC: 1.92 M

VANGUARD CAPITAL MANAGEMENT LLC: 1.92 M

STATE STREET CORP: 1.9 M

RENAISSANCE TECHNOLOGIES LLC: 1.71 M

98.58% of United Therapeutics Corp stock is owned by institutional investors.

Institutional investors have bought a total of 63.00 M shares in the last 24 months. This purchase volume represents approximately $33.34 B in transactions.